2021 Pediatric Hematology/Oncology Review Course | |||||||||
January 27-30, 2021 - Virtual | |||||||||
Session Report |
|||||||||
SESSION CODE AND TITLE/SPEAKER NAME |
AVG |
Average |
5 |
4 |
3 |
2 |
1 |
N |
|
| (RVC 4) Myeloproliferative, Myelodysplastic, and Histiocytic Disorders | 4.52 | This session accurately reviewed the appropriate information from the American Board of Pediatrics Subsection of Pediatric Hematology/Oncology content outline. | 4.52 | 86 | 40 | 11 | 0 | 1 | 138 |
| Kenneth L. McClain, MD PhD | 4.52 | Presenter was effective | 4.47 | 83 | 43 | 12 | 1 | 1 | 140 |
| Overall content and quality of the lecture/ course materials were excellent | 4.47 | 80 | 49 | 9 | 1 | 1 | 140 | ||
| Presentation was balanced and free of commercial bias | 4.61 | 96 | 36 | 7 | 0 | 1 | 140 |
| There are 15 comments for this session |